InVivo Therapeutics Announces Updates on the INSPIRE Study
InVivo Therapeutics Holdings Corp. (NVIV)
Last invivo therapeutics holdings corp. earnings: 5/7 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
invivotherapeutics.com/investor-relations/press-releases
Company Research
Source: Business Wire
- Announces Two New Patient Conversions - - Implements Temporary Enrollment Halt - CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV) today provided an update on the progress of the company’s INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury), which is designed to demonstrate the safety and probable benefit of the Neuro-Spinal Scaffold™ for the treatment of complete thoracic spinal cord injury (SCI). The primary endpoint of the study is defined as improvement in ASIA Impairment Scale (AIS) grade from baseline at the six-month visit. The study update includes: Update on Patient Conversions A patient improved from complete AIS A SCI to motor incomplete AIS C SCI at the one-month visit. A second
Show less
Read more
Impact Snapshot
Event Time:
NVIV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVIV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVIV alerts
High impacting InVivo Therapeutics Holdings Corp. news events
Weekly update
A roundup of the hottest topics
NVIV
News
- InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
NVIV
Sec Filings
- 2/14/24 - Form SC
- 2/13/24 - Form SC
- 2/7/24 - Form 4/A
- NVIV's page on the SEC website